Federation des caisses Desjardins du Quebec’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio IMNP Stock Details IMNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-28,000	Closed	-$5.21K	–	2235
2018 Q2	$5.21K	Buy	28,000 +10,000	+56%	+$2.83K	﹤0.01%	1894
2018 Q1	$6.3K	Buy	18,000 +11,000	+157%	+$5.24K	﹤0.01%	1822
2017 Q4	$3.99K	Hold	7,000	–	–	﹤0.01%	1918
2017 Q3	$10.6K	Buy	7,000 +4,000	+133%	+$7K	﹤0.01%	1660
2017 Q2	$9.24K	Buy	3,000 +2,000	+200%	+$5.37K	﹤0.01%	1756
2017 Q1	$2.92K	Buy	+1,000	New	+$3.61K	﹤0.01%	1618

Other funds holding IMNP

Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's IMNP Position: Q3 2018 in Review

Federation des caisses Desjardins du Quebec sold out of Immune Pharmaceuticals Inc. (IMNP) in Q3 2018, closing a stake of 28,000 shares — an estimated $5.21K sold.

Federation des caisses Desjardins du Quebec first reported a position in IMNP in Q1 2017 and held it in 6 quarters. The position peaked at $10.6K in Q3 2017. 1 fund tracked by Wall St. Rank holds IMNP as of Q3 2018.

Federation des caisses Desjardins du Quebec reported no remaining Immune Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 28,000 Immune Pharmaceuticals Inc. shares in Q3 2018, an estimated $5.21K.
Federation des caisses Desjardins du Quebec first reported a position in Immune Pharmaceuticals Inc. in Q1 2017 and held it in 6 quarters.
Federation des caisses Desjardins du Quebec's Immune Pharmaceuticals Inc. position peaked at $10.6K in Q3 2017.
1 fund tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q3 2018.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2018, filed 30 Aug 2024.